MW
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Malawi
Medical Only (Private)
Reimbursed Care Access
Most classical psychedelic compounds (psilocybin, MDMA, DMT, 5-MeO-DMT, mescaline, ibogaine, ayahuasca, 2C-X) are explicitly listed as prohibited under Malawi’s Pharmacy, Medicines and Poisons legislative schedules and have no authorised medical use outside approved research. Ketamine is an established essential anaesthetic agent used in Malawian hospitals (sometimes in short supply) and is available for medical practice; esketamine (Spravato) has no record of national registration or authorised clinical availability in Malawi.
No clinical trials found for this country yet.